See all treatments in the PatientsLikeMe system shared by patients just like you.
Brand Names:
Zelapar, Eldepryl, Emsam
What is Selegiline? Selegiline is a Monoamine Oxidase (MAO) inhibitor. It is an antidepressant and anti-Parkinson's agent. When used in combination with levodopa containing drugs such as Sinemet it can improve their efficacy by slowing the breakdown of levodopa. The transdermal product is used to treat depression.
See more information, including instructions, precautions, side effects, and interactions.
| Reason | # Patients | Percentage of patients |
|---|---|---|
| Treat Parkinson's | 145 | 58% |
| Treat my mood condition(s) | 10 | 4% |
| Other | 10 | 4% |
| Depression | 7 | 2% |
| Stiffness/Spasticity | 7 | 2% |
| disease-related symptoms | 3 | 1% |
| General health | 2 | <1% |
| Fatigue | 2 | <1% |
| Mobility | 2 | <1% |
| Support another treatment | 2 | <1% |
Other treatments patients are taking for Treat Parkinson's include Carbidopa-Levodopa, Ropinirole, and Pramipexole.
| 5mg as needed | 6 mg/24 hr all the time (24/7) | daily | 0.1 mg daily | 0.5 mg daily | 1.25 mg daily | 1.5 daily | 1.5 mg daily | 2.25 mg daily | 2.5 mg daily | 3 mg daily | 5 mg daily | 5 mg one time | 6 mg/24 hr daily | 9 mg/24 hr daily | 10 mg daily | 12 mg/24 hr daily | 12 mg daily | 15 mg daily | 20 mg daily | 40 mg daily | 125 mg daily | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1
|
1
|
7
|
1
|
2
|
9
|
1
|
1
|
2
|
18
|
1
|
33
|
1
|
3
|
4
|
70
|
2
|
1
|
5
|
2
|
1
|
1
|
||
How long current patients have been taking Selegiline or how long patients were taking Selegiline before stopping.
Results from 36 patient evaluations. See the overall results and all individual evaluations.
| Major | 21% | 4 |
|---|---|---|
| Moderate | 26% | 5 |
| Slight | 26% | 5 |
| None | 5% | 1 |
| Can't tell | 21% | 4 |
Treat Parkinson's
| Severe | 17% | 6 |
|---|---|---|
| Moderate | 6% | 2 |
| Mild | 14% | 5 |
| None | 64% | 23 |
Top reported side-effects include: trouble falling asleep, Dietary restrictions, Insomnia
Summary results are based on 36 individual responses. For more information, see overall results for Adherence, Burden and Cost.
Report created on November 08, 2009.